Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Exp Immunol ; 177(1): 353-65, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24654803

RESUMO

The spontaneous crescentic glomerulonephritis-forming/Kinjoh (SCG/Kj) mouse, a model of human crescentic glomerulonephritis (CrGN) and systemic vasculitis, is characterized by the production of myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody (MPO-ANCA) and marked leucocytosis. This study was performed to identify the specific populations of leucocytes associated with CrGN and susceptibility loci for pathogenic leucocytosis. Four hundred and twenty female (C57BL/6 × SCG/Kj) F2 intercross mice were subjected to serial flow cytometry examination of the peripheral blood (PB). Kidney granulocytes and monocytes were examined histopathologically. Linkage analyses were performed with 109 polymorphic microsatellite markers. Correlation studies revealed that increase of the granulocytes, F4/80(+) cells, CD3(+) CD4(-) CD8(-) T cells and dendritic cells (DCs) in peripheral blood (PB) were associated significantly with glomerulonephritis, crescent formation and vasculitis. In kidney sections, F4/80(low) cells were observed in crescent, while F4/80(high) cells were around the Bowman's capsules and in the interstitium. Numbers of F4/80(+) cells in crescents correlated significantly with F4/80(+) cell numbers in PB, but not with numbers of F4/80(+) cells in the interstitium. Genome-wide quantitative trait locus (QTL) mapping revealed three SCG/Kj-derived non-Fas QTLs for leucocytosis, two on chromosome 1 and one on chromosome 17. QTLs on chromosome 1 affected DCs, granulocytes and F4/80(+) cells, but QTL on chromosome 17 affected DCs and granulocytes. We found CrGN-associated leucocytes and susceptibility QTLs with their positional candidate genes. F4/80(+) cells in crescents are considered as recruited inflammatory macrophages. The results provide information for leucocytes to be targeted and genetic elements in CrGN and vasculitis.


Assuntos
Predisposição Genética para Doença , Glomerulonefrite/genética , Leucocitose/genética , Monócitos/imunologia , Locos de Características Quantitativas , Vasculite Sistêmica/genética , Animais , Anticorpos Anticitoplasma de Neutrófilos/sangue , Antígenos de Diferenciação/metabolismo , Autoantígenos/imunologia , Movimento Celular/genética , Modelos Animais de Doenças , Feminino , Ligação Genética , Granulócitos/imunologia , Humanos , Rim/patologia , Camundongos , Camundongos Endogâmicos C57BL , Repetições de Microssatélites/genética , Peroxidase/imunologia
2.
Cell Biol Int ; 28(6): 463-9, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15223023

RESUMO

We investigated the action of bisphenol A (BPA) on cellular GH release and content, cell number, GHmRNA expression, and concentrations of cellular cyclic AMP ([cAMP]c) and calcium ion ([Ca2+]c) in primary cultured ovine anterior pituitary cells. The following results were found: (1) BPA as well as nonylphenol (NP) at 10(-6) to 10(-3) M significantly and concentration-dependently suppressed basal and GHRH-stimulated GH release, and the cellular GH content, (2) BPA suppressed the cell number in a time- and concentration-dependent manner, (3) 10(-4)M BPA suppressed GHmRNA expression to 68% of control (BPA-free), and abolished GHRH (10(-8) M)-induced increases in [cAMP]c and [Ca2+]c. From these findings we conclude that BPA possesses a suppressing action on GH synthesis and release, and this suppressing action is probably related to impairment of cellular signal transduction systems in ovine anterior pituitary cells.


Assuntos
Fenóis/farmacologia , Adeno-Hipófise/efeitos dos fármacos , Adeno-Hipófise/metabolismo , Animais , Compostos Benzidrílicos , Cálcio/metabolismo , Contagem de Células , AMP Cíclico/metabolismo , Regulação da Expressão Gênica , Hormônio do Crescimento/efeitos dos fármacos , Hormônio do Crescimento/metabolismo , Hormônio Liberador de Hormônio do Crescimento/genética , Hormônio Liberador de Hormônio do Crescimento/farmacologia , Adeno-Hipófise/citologia , RNA Mensageiro/genética , Ovinos , Fatores de Tempo
3.
Pathol Int ; 51(7): 491-7, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11472560

RESUMO

Senescence marker protein 30 (SMP 30) is preferentially expressed in the liver. One of its remarkable functions is the protection of cells against various injuries by enhancement of membrane calcium-pump activity. We analyzed the role of SMP 30 in hepatocyte proliferation. SMP 30 expression was decreased initially, then increased along with hepatic regeneration, after carbon tetrachloride (CCl4) administration. SMP 30 expression was decreased in the necrotic phase and then gradually increased. Its increase was slightly delayed just after the mitotic phase. These results lead us to speculate that mitoses of hepatic cells induce enhanced SMP 30 expression. In contrast, administration of lead nitrate (LN) as a hepatic mitogen induced a more stable increase of SMP 30 expression. To estimate the effect of SMP 30 on cell proliferation, we evaluated hepatic mitosis in wild-type and SMP 30-deficient knockout (KO) mice after CCl4 administration. We found an increase in mitotic numbers in hepatocytes of KO mice. This result suggests that SMP 30 has a suppressive effect on cell proliferation. Suppressive activity of SMP 30 cDNA was shown in cultured hepatoblastic cells. Our results suggest that SMP 30 performs a regulatory function in liver regeneration.


Assuntos
Proteínas de Ligação ao Cálcio/metabolismo , Hepatócitos/metabolismo , Animais , Northern Blotting , Proteínas de Ligação ao Cálcio/genética , Tetracloreto de Carbono/toxicidade , Divisão Celular/efeitos dos fármacos , Divisão Celular/fisiologia , Hepatócitos/efeitos dos fármacos , Hepatócitos/patologia , Chumbo/farmacologia , Regeneração Hepática/efeitos dos fármacos , Regeneração Hepática/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Mitógenos/farmacologia , Nitratos/farmacologia , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Sulfotransferases , Transfecção , Células Tumorais Cultivadas
4.
J Biol Chem ; 274(39): 27786-92, 1999 Sep 24.
Artigo em Inglês | MEDLINE | ID: mdl-10488123

RESUMO

Three types of peptidylarginine deiminase (PAD), which converts a protein arginine residue to a citrulline residue, are widely distributed in animal tissues. Little is known about PAD of hemopoietic cells. We found that PAD activity in human myeloid leukemia HL-60 cells was induced with the granulocyte-inducing agents retinoic acid and dimethyl sulfoxide and with the monocyte-inducing agent 1alpha,25-dihydroxyvitamin D(3). We cloned and characterized a PAD cDNA from retinoic acid-induced cells. The cDNA was 2,238 base pairs long and encoded a 663-amino acid polypeptide. The HL-60 PAD had 50-55% amino acid sequence identities with the three known enzymes and 73% identity with the recently cloned keratinocyte PAD. The recombinant enzyme differs in kinetic properties from the known enzymes. Immunoblotting and Northern blotting with an antiserum against the enzyme and the cDNA, respectively, showed that a protein of approximately 67 kDa increased concomitantly with increase of mRNA of approximately 2.6 kilobases during granulocyte differentiation. During monocyte differentiation the same mRNA and protein increased as in granulocyte differentiation. Neither the enzyme activity nor the protein was found in macrophage-induced cells. These results suggested that expression of the PAD gene is tightly linked to myeloid differentiation.


Assuntos
Calcitriol/farmacologia , Hidrolases/biossíntese , Hidrolases/genética , Tretinoína/farmacologia , Sequência de Aminoácidos , Sequência de Bases , Diferenciação Celular/efeitos dos fármacos , Primers do DNA , Indução Enzimática , Biblioteca Gênica , Granulócitos/citologia , Granulócitos/enzimologia , Células HL-60 , Humanos , Hidrolases/metabolismo , Queratinócitos/enzimologia , Cinética , Dados de Sequência Molecular , Proteína-Arginina Desiminase do Tipo 4 , Desiminases de Arginina em Proteínas , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/metabolismo , Alinhamento de Sequência , Ésteres do Ácido Sulfúrico/farmacologia , Acetato de Tetradecanoilforbol/farmacologia
5.
Biochem Biophys Res Commun ; 196(1): 181-6, 1993 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-8216291

RESUMO

Epidermal growth factor (EGF) stimulated DNA synthesis and EGF receptor levels were examined in primary cultured hepatocytes from 6, 12 and 24 month old rats. EGF stimulated DNA synthesis began after 12h and reached a peak at 48 h. Although no age difference was seen in the time course of DNA synthesis, the magnitude of synthesis at the peak time in 12 and 24 month old rat hepatocytes was reduced approximately 50 and 70%, as compared to that at 6 months. Hepatocyte EGF receptors exhibited no age difference in the equilibrium dissociation constant (Kd) or the density (Bmax). These results indicate that EGF stimulated DNA synthesis in rat hepatocytes declines with age, and that this reduction is not due to decreased receptor density or specific binding affinity.


Assuntos
Envelhecimento/metabolismo , Fator de Crescimento Epidérmico/metabolismo , Receptores ErbB/metabolismo , Fígado/metabolismo , Animais , Afidicolina/farmacologia , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Fator de Crescimento Epidérmico/farmacologia , Fígado/citologia , Fígado/efeitos dos fármacos , Masculino , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA